- Home
- SNSE vs BREA Comparison
SNSE vs BREA Comparison
Compare SNSE & BREA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SNSE
- BREA
- Stock Information
- Founded
- SNSE 2005
- BREA 2022
- Country
- SNSE United States
- BREA Ireland
- Employees
- SNSE N/A
- BREA N/A
- Industry
- SNSE Biotechnology: Pharmaceutical Preparations
- BREA Services-Misc. Amusement & Recreation
- Sector
- SNSE Health Care
- BREA Consumer Discretionary
- Exchange
- SNSE Nasdaq
- BREA Nasdaq
- Market Cap
- SNSE 9.3M
- BREA 9.4M
- IPO Year
- SNSE 2021
- BREA 2023
- Fundamental
- Price
- SNSE $0.34
- BREA $0.67
- Analyst Decision
- SNSE Strong Buy
- BREA
- Analyst Count
- SNSE 4
- BREA 0
- Target Price
- SNSE $4.25
- BREA N/A
- AVG Volume (30 Days)
- SNSE 111.9K
- BREA 70.7K
- Earning Date
- SNSE 05-06-2025
- BREA 01-03-2025
- Dividend Yield
- SNSE N/A
- BREA N/A
- EPS Growth
- SNSE N/A
- BREA N/A
- EPS
- SNSE N/A
- BREA N/A
- Revenue
- SNSE N/A
- BREA $2,988,009.00
- Revenue This Year
- SNSE N/A
- BREA N/A
- Revenue Next Year
- SNSE N/A
- BREA N/A
- P/E Ratio
- SNSE N/A
- BREA N/A
- Revenue Growth
- SNSE N/A
- BREA 151.51
- 52 Week Low
- SNSE $0.25
- BREA $0.50
- 52 Week High
- SNSE $1.94
- BREA $1.95
- Technical
- Relative Strength Index (RSI)
- SNSE 41.60
- BREA 47.09
- Support Level
- SNSE $0.32
- BREA $0.63
- Resistance Level
- SNSE $0.38
- BREA $0.69
- Average True Range (ATR)
- SNSE 0.03
- BREA 0.04
- MACD
- SNSE -0.00
- BREA -0.01
- Stochastic Oscillator
- SNSE 21.49
- BREA 28.93
About SNSE Sensei Biotherapeutics Inc.
Sensei Biotherapeutics Inc is an immuno-oncology company focused on the discovery and development of next-generation therapeutics for cancer patients. Its TMAb (Tumor Microenvironment Activated Biologics) platform developing selective therapeutics designed to disable immunosuppressive signals or activate immunostimulatory signals selectively in the tumor microenvironment. The company have four investigational product candidates in various stages of development: SNS-101 (VISTA), SNS-102 (VSIG4 ), SNS-103 (ENTPDase/CD39), SNS-201 (VISTAxCD28).
About BREA Brera Holdings PLC
Brera Holdings PLC focused on expanding social impact football by developing a international portfolio of emerging football clubs with increased opportunities to earn tournament prizes, gain sponsorships, and provide other professional football and related consulting services.